SCHEMBL6329876

SCHEMBL6329876

CC(Sc1ccc(-c2nc(C(=O)Nc3ccc(C(F)(F)F)cc3)c(-c3ccccc3)s2)cc1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ PPARA Q07869 3/20 0.44
▸ DGAT1 O75907 6/20 0.43
▸ NR1H4 Q96RI1 1/20 0.43
▸ LMNA P02545 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ FFAR1 O14842 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ ROCK1 Q13464 1/20 0.41
▸ PPARD Q03181 3/20 0.41
▸ MMP2 P08253 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP8 P22894 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6330354 0.90 ALOX5 (0.45) MAPTMEN1KMT2ADGAT1HTT
SCHEMBL6333154 0.89 MAPT (0.47) MAPTMEN1KMT2ADGAT1LMNA
SCHEMBL6326492 0.88 MAPT (0.45) MAPTMEN1KMT2ADGAT1LMNA
SCHEMBL6327448 0.87 STAT3 (0.51) MAPTMEN1KMT2ALMNAHTT
SCHEMBL6325802 0.84 LMNA (0.46) MAPTMEN1KMT2APPARANR1H4
Trifluoroacetic Acid SCHEMBL6326606 0.83 DGAT1 (0.51) MAPTDGAT1NPC1RAB9AL3MBTL1
SCHEMBL6333062 0.81 ALOX5 (0.43) MEN1KMT2AL3MBTL1
SCHEMBL6330411 0.80 PPARA (0.69) MAPTMEN1KMT2APPARAPPARD
SCHEMBL6336683 0.79 KDM4E (0.53) MAPTKMT2ALMNAHTTNPC1
SCHEMBL6335252 0.79 PPARA (0.49) MAPTMEN1KMT2APPARANR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION 2005-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity GPR119, EGLN3, PC MAPT 3022/4885MEN1 3157/4885KMT2A 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback